Will Ssengooba is an infectious diseases expert with a focus on pathogenesis, diagnostics, and program implementation using both conventional microbiological methods and modern molecular approaches. In this regard, he has acquired the necessary skills, and established laboratory-based research capacity in Uganda and beyond. He has advanced skills in Molecular Epidemiology and Bioinformatics.

George William Kasule is a biomedical laboratory technologist with a Bachelors and Master’s degree in biomedical laboratory sciences from Makerere University, Uganda. He has attained about ten year’s working experience at Uganda National TB Reference laboratory/WHO supranational reference laboratory in number of roles and gained expertise in routine TB diagnosis, Quality Management System, TB drug resistance and prevalence surveys, External Quality Assessment and strengthening TB laboratory diagnosis in a number of countries in Sub Saharan Africa. He has a passion for operational and translational science research especially in HIV/TB co-infection and TB diagnostics (ORCID 0000-0002-2123-9614). He joined the Stool4TB project (www.stool4tb.org) in October 2021 as a PhD candidate from Uganda. His PhD research is nested in the Stool4TB project; ‘Evaluation of non-sputum based biomarkers for TB diagnosis among children and People Living with HIV.

Ivan Sserwadda is currently a PhD fellow under the Amsterdam Institute for Global Health and Development (AIGHD) and the CAGE-TB project where he focuses on exploiting Microbiome studies to understand the progression and pathogenesis of Tuberculosis in Uganda.

Kevin Komakech is a Biomedical Laboratory scientist with about 10 years’ working experience in diverse TB diagnostics. He obtained his Bachelors and Master’s degree at Makerere University and currently pursuing a PhD at Amsterdam Institute for Global Health and Development (ORCID 0000-0002-4547-212x).

Victor Ssempijja is a Biostatistician and methods epidemiologist. His research explores application of statistical and epidemiological methods to innovate and enhance public health interventions and structural changes for community advancements. His PhD desertion studies acceleration of HIV epidemic control through optimizing use of anti-retroviral therapies (ART) for HIV prevention and treatment. The dissertation is framed by population-based studies that explore opportunities for enhancing effectiveness and use of ARTs to prevent new HIV cases and sustain viral suppression in persons living with HIV.